Halozyme Therapeutics Inc (HALO) — Defensive Interval Ratio
Halozyme Therapeutics Inc (HALO) has a Defensive Interval Ratio of 274 days as of September 2025. Defensive assets of $628.33 Million (cash $-, short-term investments $282.30 Million, receivables $346.04 Million) cover 274 days of daily cash needs of $2.29 Million/day. Check tangible equity quality of Halozyme Therapeutics Inc to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Halozyme Therapeutics Inc Defensive Interval Ratio (2005–2024)
This chart shows how Halozyme Therapeutics Inc's Defensive Interval Ratio has evolved across 20 annual periods from 2005 to 2024. As of September 2025, the ratio stands at 274 days, meaning defensive assets of $628.33 Million can fund 274 days of operations without new revenue. Also explore Halozyme Therapeutics Inc equity growth rate to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Halozyme Therapeutics Inc (2005–2024)
The table below presents the year-by-year Defensive Interval Ratio for Halozyme Therapeutics Inc from 2005 to 2024, covering 20 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see HALO stock market capitalisation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 2070 days | $788.68 Million | $381.10K/day | $- | $480.22 Million | ▲ +603 days |
| 2023 | 1466 days | $451.84 Million | $308.20K/day | $- | $217.63 Million | ▲ +462 days |
| 2022 | 1004 days | $359.67 Million | $358.33K/day | $- | $128.60 Million | ▼ -1218 days |
| 2021 | 2222 days | $713.18 Million | $320.95K/day | $- | $622.20 Million | ▲ +1947 days |
| 2020 | 275 days | $318.04 Million | $1.15 Million/day | $- | $220.31 Million | ▼ -1261 days |
| 2019 | 1537 days | $360.52 Million | $234.62K/day | $- | $301.08 Million | ▲ +739 days |
| 2018 | 798 days | $326.60 Million | $409.21K/day | $- | $296.59 Million | ▼ -99 days |
| 2017 | 897 days | $322.61 Million | $359.80K/day | $- | $300.47 Million | ▼ -132 days |
| 2016 | 1029 days | $153.90 Million | $149.55K/day | $- | $138.22 Million | ▲ +460 days |
| 2015 | 570 days | $97.46 Million | $171.12K/day | $- | $65.05 Million | ▼ -681 days |
| 2014 | 1251 days | $83.38 Million | $66.66K/day | $- | $74.23 Million | ▲ +487 days |
| 2013 | 764 days | $53.24 Million | $69.73K/day | $- | $44.15 Million | ▲ +461 days |
| 2012 | 303 days | $15.70 Million | $51.91K/day | $- | $0.00 | ▲ +255 days |
| 2011 | 48 days | $2.26 Million | $47.40K/day | $- | $0.00 | ▼ -8 days |
| 2010 | 55 days | $2.33 Million | $42.04K/day | $- | $- | ▼ -52 days |
| 2009 | 108 days | $4.24 Million | $39.44K/day | $- | $- | ▼ -79 days |
| 2008 | 186 days | $7.26 Million | $38.95K/day | $- | $- | ▲ +154 days |
| 2007 | 32 days | $779.83K | $24.29K/day | $- | $- | ▼ -14 days |
| 2006 | 46 days | $533.39K | $11.65K/day | $- | $- | ▼ -20 days |
| 2005 | 66 days | $413.83K | $6.31K/day | $- | $- | — |